Alere is working with the FDA to determine the most appropriate timing for product discontinuation and will provide guidance on transitioning patients to an alternate solution.
Read more: INRatio and INRatio2 PT/INR Monitor System by Alere: Recall - Potentially Inaccurate INR Results